TYK Medicines, Inc
Status: Publicly traded
Direct answer
TYK Medicines, Inc is publicly traded on HKSE under the ticker 2410.HK.
TYK Medicines, Inc. is a biopharmaceutical firm in the clinical development phase, dedicated to identifying, obtaining, advancing, and bringing to market innovative treatments for significant unmet needs in oncology. The company's primary drug candidate, TY-9591, is a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI). It is being developed to treat non-small cell lung cancer...
Can you invest in TYK Medicines, Inc?
Yes. TYK Medicines, Inc is publicly traded on HKSE under the ticker 2410.HK.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for TYK Medicines, Inc
Detailed equity research is provided by MarketSnap.